Global Opioids Drug Market Insights, Forecast to 2029

Global Opioids Drug Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Opioids Drug Product Introduction
1.2 Market by Type
1.2.1 Global Opioids Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Market by Application
1.3.1 Global Opioids Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Opioids Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Opioids Drug Revenue by Region
2.2.1 Global Opioids Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Opioids Drug Revenue by Region (2018-2023)
2.2.3 Global Opioids Drug Revenue by Region (2024-2029)
2.2.4 Global Opioids Drug Revenue Market Share by Region (2018-2029)
2.3 Global Opioids Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Opioids Drug Sales by Region
2.4.1 Global Opioids Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Opioids Drug Sales by Region (2018-2023)
2.4.3 Global Opioids Drug Sales by Region (2024-2029)
2.4.4 Global Opioids Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Opioids Drug Sales by Manufacturers
3.1.1 Global Opioids Drug Sales by Manufacturers (2018-2023)
3.1.2 Global Opioids Drug Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Opioids Drug in 2022
3.2 Global Opioids Drug Revenue by Manufacturers
3.2.1 Global Opioids Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Opioids Drug Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Opioids Drug Revenue in 2022
3.3 Global Key Players of Opioids Drug, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Opioids Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Opioids Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Opioids Drug, Product Offered and Application
3.8 Global Key Manufacturers of Opioids Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Opioids Drug Sales by Type
4.1.1 Global Opioids Drug Historical Sales by Type (2018-2023)
4.1.2 Global Opioids Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Opioids Drug Sales Market Share by Type (2018-2029)
4.2 Global Opioids Drug Revenue by Type
4.2.1 Global Opioids Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Opioids Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Opioids Drug Revenue Market Share by Type (2018-2029)
4.3 Global Opioids Drug Price by Type
4.3.1 Global Opioids Drug Price by Type (2018-2023)
4.3.2 Global Opioids Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Opioids Drug Sales by Application
5.1.1 Global Opioids Drug Historical Sales by Application (2018-2023)
5.1.2 Global Opioids Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Opioids Drug Sales Market Share by Application (2018-2029)
5.2 Global Opioids Drug Revenue by Application
5.2.1 Global Opioids Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Opioids Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Opioids Drug Revenue Market Share by Application (2018-2029)
5.3 Global Opioids Drug Price by Application
5.3.1 Global Opioids Drug Price by Application (2018-2023)
5.3.2 Global Opioids Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Opioids Drug Market Size by Type
6.1.1 US & Canada Opioids Drug Sales by Type (2018-2029)
6.1.2 US & Canada Opioids Drug Revenue by Type (2018-2029)
6.2 US & Canada Opioids Drug Market Size by Application
6.2.1 US & Canada Opioids Drug Sales by Application (2018-2029)
6.2.2 US & Canada Opioids Drug Revenue by Application (2018-2029)
6.3 US & Canada Opioids Drug Market Size by Country
6.3.1 US & Canada Opioids Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Opioids Drug Sales by Country (2018-2029)
6.3.3 US & Canada Opioids Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Opioids Drug Market Size by Type
7.1.1 Europe Opioids Drug Sales by Type (2018-2029)
7.1.2 Europe Opioids Drug Revenue by Type (2018-2029)
7.2 Europe Opioids Drug Market Size by Application
7.2.1 Europe Opioids Drug Sales by Application (2018-2029)
7.2.2 Europe Opioids Drug Revenue by Application (2018-2029)
7.3 Europe Opioids Drug Market Size by Country
7.3.1 Europe Opioids Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Opioids Drug Sales by Country (2018-2029)
7.3.3 Europe Opioids Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Opioids Drug Market Size
8.1.1 China Opioids Drug Sales (2018-2029)
8.1.2 China Opioids Drug Revenue (2018-2029)
8.2 China Opioids Drug Market Size by Application
8.2.1 China Opioids Drug Sales by Application (2018-2029)
8.2.2 China Opioids Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Opioids Drug Market Size by Type
9.1.1 Asia Opioids Drug Sales by Type (2018-2029)
9.1.2 Asia Opioids Drug Revenue by Type (2018-2029)
9.2 Asia Opioids Drug Market Size by Application
9.2.1 Asia Opioids Drug Sales by Application (2018-2029)
9.2.2 Asia Opioids Drug Revenue by Application (2018-2029)
9.3 Asia Opioids Drug Sales by Region
9.3.1 Asia Opioids Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Opioids Drug Revenue by Region (2018-2029)
9.3.3 Asia Opioids Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Opioids Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Opioids Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Opioids Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Opioids Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Opioids Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Opioids Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Opioids Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Opioids Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Opioids Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Opioids Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Overview
11.1.3 Teva Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Teva Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Purdue Pharma
11.2.1 Purdue Pharma Company Information
11.2.2 Purdue Pharma Overview
11.2.3 Purdue Pharma Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Purdue Pharma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Purdue Pharma Recent Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Information
11.3.2 Mallinckrodt Overview
11.3.3 Mallinckrodt Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Mallinckrodt Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mallinckrodt Recent Developments
11.4 Amneal Pharma
11.4.1 Amneal Pharma Company Information
11.4.2 Amneal Pharma Overview
11.4.3 Amneal Pharma Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Amneal Pharma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amneal Pharma Recent Developments
11.5 Collegium
11.5.1 Collegium Company Information
11.5.2 Collegium Overview
11.5.3 Collegium Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Collegium Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Collegium Recent Developments
11.6 J&J
11.6.1 J&J Company Information
11.6.2 J&J Overview
11.6.3 J&J Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 J&J Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 J&J Recent Developments
11.7 Endo
11.7.1 Endo Company Information
11.7.2 Endo Overview
11.7.3 Endo Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Endo Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Endo Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Pfizer Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 INSYS
11.9.1 INSYS Company Information
11.9.2 INSYS Overview
11.9.3 INSYS Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 INSYS Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 INSYS Recent Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Overview
11.10.3 Mylan Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Mylan Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Recent Developments
11.11 Hikma
11.11.1 Hikma Company Information
11.11.2 Hikma Overview
11.11.3 Hikma Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Hikma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hikma Recent Developments
11.12 Egalet
11.12.1 Egalet Company Information
11.12.2 Egalet Overview
11.12.3 Egalet Opioids Drug Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Egalet Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Egalet Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Opioids Drug Industry Chain Analysis
12.2 Opioids Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Opioids Drug Production Mode & Process
12.4 Opioids Drug Sales and Marketing
12.4.1 Opioids Drug Sales Channels
12.4.2 Opioids Drug Distributors
12.5 Opioids Drug Customers
13 Market Dynamics
13.1 Opioids Drug Industry Trends
13.2 Opioids Drug Market Drivers
13.3 Opioids Drug Market Challenges
13.4 Opioids Drug Market Restraints
14 Key Findings in The Global Opioids Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Opioids Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oxycodone
Table 3. Major Manufacturers of Hydromorphone
Table 4. Major Manufacturers of Codeine
Table 5. Major Manufacturers of Fentanyl
Table 6. Global Opioids Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Opioids Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Opioids Drug Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Opioids Drug Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Opioids Drug Revenue Market Share by Region (2018-2023)
Table 11. Global Opioids Drug Revenue Market Share by Region (2024-2029)
Table 12. Global Opioids Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Opioids Drug Sales by Region (2018-2023) & (M Units)
Table 14. Global Opioids Drug Sales by Region (2024-2029) & (M Units)
Table 15. Global Opioids Drug Sales Market Share by Region (2018-2023)
Table 16. Global Opioids Drug Sales Market Share by Region (2024-2029)
Table 17. Global Opioids Drug Sales by Manufacturers (2018-2023) & (M Units)
Table 18. Global Opioids Drug Sales Share by Manufacturers (2018-2023)
Table 19. Global Opioids Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Opioids Drug Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Opioids Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Opioids Drug Price by Manufacturers 2018-2023 (USD/Unit)
Table 23. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Opioids Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Drug as of 2022)
Table 25. Global Key Manufacturers of Opioids Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Opioids Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Opioids Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 30. Global Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 31. Global Opioids Drug Sales Share by Type (2018-2023)
Table 32. Global Opioids Drug Sales Share by Type (2024-2029)
Table 33. Global Opioids Drug Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Opioids Drug Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Opioids Drug Revenue Share by Type (2018-2023)
Table 36. Global Opioids Drug Revenue Share by Type (2024-2029)
Table 37. Opioids Drug Price by Type (2018-2023) & (USD/Unit)
Table 38. Global Opioids Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 40. Global Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 41. Global Opioids Drug Sales Share by Application (2018-2023)
Table 42. Global Opioids Drug Sales Share by Application (2024-2029)
Table 43. Global Opioids Drug Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Opioids Drug Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Opioids Drug Revenue Share by Application (2018-2023)
Table 46. Global Opioids Drug Revenue Share by Application (2024-2029)
Table 47. Opioids Drug Price by Application (2018-2023) & (USD/Unit)
Table 48. Global Opioids Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 50. US & Canada Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 51. US & Canada Opioids Drug Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Opioids Drug Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 54. US & Canada Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 55. US & Canada Opioids Drug Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Opioids Drug Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Opioids Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Opioids Drug Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Opioids Drug Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Opioids Drug Sales by Country (2018-2023) & (M Units)
Table 61. US & Canada Opioids Drug Sales by Country (2024-2029) & (M Units)
Table 62. Europe Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 63. Europe Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 64. Europe Opioids Drug Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Opioids Drug Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 67. Europe Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 68. Europe Opioids Drug Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Opioids Drug Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Opioids Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Opioids Drug Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Opioids Drug Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Opioids Drug Sales by Country (2018-2023) & (M Units)
Table 74. Europe Opioids Drug Sales by Country (2024-2029) & (M Units)
Table 75. China Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 76. China Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 77. China Opioids Drug Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Opioids Drug Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 80. China Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 81. China Opioids Drug Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Opioids Drug Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 84. Asia Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 85. Asia Opioids Drug Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Opioids Drug Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 88. Asia Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 89. Asia Opioids Drug Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Opioids Drug Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Opioids Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Opioids Drug Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Opioids Drug Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Opioids Drug Sales by Region (2018-2023) & (M Units)
Table 95. Asia Opioids Drug Sales by Region (2024-2029) & (M Units)
Table 96. Middle East, Africa and Latin America Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 97. Middle East, Africa and Latin America Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 98. Middle East, Africa and Latin America Opioids Drug Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Opioids Drug Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 101. Middle East, Africa and Latin America Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 102. Middle East, Africa and Latin America Opioids Drug Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Opioids Drug Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Opioids Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Opioids Drug Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Opioids Drug Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Opioids Drug Sales by Country (2018-2023) & (M Units)
Table 108. Middle East, Africa and Latin America Opioids Drug Sales by Country (2024-2029) & (M Units)
Table 109. Teva Company Information
Table 110. Teva Description and Major Businesses
Table 111. Teva Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Teva Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Teva Recent Developments
Table 114. Purdue Pharma Company Information
Table 115. Purdue Pharma Description and Major Businesses
Table 116. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Purdue Pharma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Purdue Pharma Recent Developments
Table 119. Mallinckrodt Company Information
Table 120. Mallinckrodt Description and Major Businesses
Table 121. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Mallinckrodt Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Mallinckrodt Recent Developments
Table 124. Amneal Pharma Company Information
Table 125. Amneal Pharma Description and Major Businesses
Table 126. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Amneal Pharma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Amneal Pharma Recent Developments
Table 129. Collegium Company Information
Table 130. Collegium Description and Major Businesses
Table 131. Collegium Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Collegium Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Collegium Recent Developments
Table 134. J&J Company Information
Table 135. J&J Description and Major Businesses
Table 136. J&J Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. J&J Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. J&J Recent Developments
Table 139. Endo Company Information
Table 140. Endo Description and Major Businesses
Table 141. Endo Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 142. Endo Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Endo Recent Developments
Table 144. Pfizer Company Information
Table 145. Pfizer Description and Major Businesses
Table 146. Pfizer Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. Pfizer Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Pfizer Recent Developments
Table 149. INSYS Company Information
Table 150. INSYS Description and Major Businesses
Table 151. INSYS Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. INSYS Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. INSYS Recent Developments
Table 154. Mylan Company Information
Table 155. Mylan Description and Major Businesses
Table 156. Mylan Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 157. Mylan Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Mylan Recent Developments
Table 159. Hikma Company Information
Table 160. Hikma Description and Major Businesses
Table 161. Hikma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 162. Hikma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Hikma Recent Developments
Table 164. Egalet Company Information
Table 165. Egalet Description and Major Businesses
Table 166. Egalet Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 167. Egalet Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Egalet Recent Developments
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Opioids Drug Distributors List
Table 172. Opioids Drug Customers List
Table 173. Opioids Drug Market Trends
Table 174. Opioids Drug Market Drivers
Table 175. Opioids Drug Market Challenges
Table 176. Opioids Drug Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Drug Product Picture
Figure 2. Global Opioids Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Opioids Drug Market Share by Type in 2022 & 2029
Figure 4. Oxycodone Product Picture
Figure 5. Hydromorphone Product Picture
Figure 6. Codeine Product Picture
Figure 7. Fentanyl Product Picture
Figure 8. Global Opioids Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Opioids Drug Market Share by Application in 2022 & 2029
Figure 10. Pain Relief
Figure 11. Anesthesia
Figure 12. Others
Figure 13. Opioids Drug Report Years Considered
Figure 14. Global Opioids Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Opioids Drug Revenue 2018-2029 (US$ Million)
Figure 16. Global Opioids Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Opioids Drug Revenue Market Share by Region (2018-2029)
Figure 18. Global Opioids Drug Sales 2018-2029 ((M Units)
Figure 19. Global Opioids Drug Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Opioids Drug Sales YoY (2018-2029) & (M Units)
Figure 21. US & Canada Opioids Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Opioids Drug Sales YoY (2018-2029) & (M Units)
Figure 23. Europe Opioids Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Opioids Drug Sales YoY (2018-2029) & (M Units)
Figure 25. China Opioids Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Opioids Drug Sales YoY (2018-2029) & (M Units)
Figure 27. Asia (excluding China) Opioids Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Opioids Drug Sales YoY (2018-2029) & (M Units)
Figure 29. Middle East, Africa and Latin America Opioids Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Opioids Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Opioids Drug in the World: Market Share by Opioids Drug Revenue in 2022
Figure 32. Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Opioids Drug Sales Market Share by Type (2018-2029)
Figure 34. Global Opioids Drug Revenue Market Share by Type (2018-2029)
Figure 35. Global Opioids Drug Sales Market Share by Application (2018-2029)
Figure 36. Global Opioids Drug Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Opioids Drug Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Opioids Drug Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Opioids Drug Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Opioids Drug Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Opioids Drug Revenue Share by Country (2018-2029)
Figure 42. US & Canada Opioids Drug Sales Share by Country (2018-2029)
Figure 43. U.S. Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Opioids Drug Sales Market Share by Type (2018-2029)
Figure 46. Europe Opioids Drug Revenue Market Share by Type (2018-2029)
Figure 47. Europe Opioids Drug Sales Market Share by Application (2018-2029)
Figure 48. Europe Opioids Drug Revenue Market Share by Application (2018-2029)
Figure 49. Europe Opioids Drug Revenue Share by Country (2018-2029)
Figure 50. Europe Opioids Drug Sales Share by Country (2018-2029)
Figure 51. Germany Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 52. France Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 56. China Opioids Drug Sales Market Share by Type (2018-2029)
Figure 57. China Opioids Drug Revenue Market Share by Type (2018-2029)
Figure 58. China Opioids Drug Sales Market Share by Application (2018-2029)
Figure 59. China Opioids Drug Revenue Market Share by Application (2018-2029)
Figure 60. Asia Opioids Drug Sales Market Share by Type (2018-2029)
Figure 61. Asia Opioids Drug Revenue Market Share by Type (2018-2029)
Figure 62. Asia Opioids Drug Sales Market Share by Application (2018-2029)
Figure 63. Asia Opioids Drug Revenue Market Share by Application (2018-2029)
Figure 64. Asia Opioids Drug Revenue Share by Region (2018-2029)
Figure 65. Asia Opioids Drug Sales Share by Region (2018-2029)
Figure 66. Japan Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 70. India Opioids Drug Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Opioids Drug Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Opioids Drug Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Opioids Drug Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Opioids Drug Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Opioids Drug Revenue Share by Country (2018-2029)
Figure

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs